All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Avenue Therapeutics, Inc. earnings schedule

Avenue Therapeutics, Inc. quarterly earnings, ATXI earnings report for 2024. When does Avenue Therapeutics, Inc. report earnings?
Add to widgets
Added to widgets

When does Avenue Therapeutics, Inc. report earnings?

Avenue Therapeutics, Inc. reports earnings every quartal, last Avenue Therapeutics, Inc. earnings report date was 31/03/2021.

How much is Avenue Therapeutics, Inc. earnings per share?

Avenue Therapeutics, Inc. estimated earnings per share was -0.06 $ last time.

When is Avenue Therapeutics, Inc. next earnings report?

Next Avenue Therapeutics, Inc. earnings call will be in June 2024.

Avenue Therapeutics, Inc. earnings per share of a financial organization is a calculated indicator of the success of a company, tied to the value of the organization itself. Earnings per share are calculated according to the formula: the amount of the company's profit for the financial period according to official reports is divided by the number of shares in the company. Obviously, Avenue Therapeutics, Inc. earnings per share is a variable indicator for a specific financial period. Profit of Avenue Therapeutics, Inc. - the organization’s reported profit for the financial interval specified by law.

Show:
to

Avenue Therapeutics, Inc. earnings report

Avenue Therapeutics, Inc. total profit is for reference only and is not interesting to individual shareholders. Shareholders are more interested in earnings per share. It primarily affects the received dividends on shares. The date of the profit report Avenue Therapeutics, Inc. is tied to the legislation of the country of registration of the company. Each date of Avenue Therapeutics, Inc. profit statement corresponds to a line in the service table.

Avenue Therapeutics, Inc. quarterly earnings

Earnings per share Avenue Therapeutics, Inc. is calculated by dividing the company's profit by the number of its shares. Earnings per share Avenue Therapeutics, Inc. is an indicator of a certain financial interval. It is easy to guess that the financial period coincides with the publication of financial statements of profit. Avenue Therapeutics, Inc. earnings per share for the most recent period are on the graph in the rightmost column. Avenue Therapeutics, Inc. quarterly earnings for financial analytics is the main interim report for the financial year.

ATXI earnings date Estimated EPS
A company's earnings per share, or EPS, is calculated by dividing net income (or profits) to the number of company's shares.
Change for a year %
31/03/2021 -0.06 USD -
31/12/2020 -0.06 USD -
30/09/2020 -0.06 USD -57.143% ↓
30/06/2020 -0.11 USD -74.419% ↓
30/09/2019 -0.14 USD -15.152% ↓
30/06/2019 -0.43 USD -
31/03/2019 -0.82 USD -
31/12/2018 -0.37 USD -
30/09/2018 -0.25 USD -

Avenue Therapeutics, Inc. quarterly earnings per share is also one of the organization’s profitability indicators, although less popular than annual earnings per share. Last quarterly profit Avenue Therapeutics, Inc. is now considered to be quarterly profit for the last closed fiscal quarter of this year. Change in profit Avenue Therapeutics, Inc. for the year is a reference value showing the dynamics of profit compared to the same period last year. A change in Avenue Therapeutics, Inc. quarterly profit for the year is not so important as a change in Avenue Therapeutics, Inc. annual profit compared to last year.

For convenience of perception and analysis, we publish the change in profit as a percentage. In the table of the Quarterly Profit service on this page, you can find the history of Avenue Therapeutics, Inc. profit for previous reporting periods, for the last year or other interval. Avenue Therapeutics, Inc. quarterly earnings history is available online over the past 10 years. The database of profit for the past year and other periods of Avenue Therapeutics, Inc. is compiled from public sources.

Avenue Therapeutics, Inc. stocks data

Avenue Therapeutics, Inc. financials